Enorama Pharma
3,16 SEK -1,25 %Vær den første som følger denne virksomhed
Enorama Pharma is a pharmaceutical company. The company's operations are focused on producing and developing medical nicotine chewing gum. The products are mainly sold through retailers who sell the product under their own brand. The largest market is established in the Nordic region, but also worldwide. The head office is located in Malmö.
Omsætning
6,85 mio.
EBIT %
-576,93 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
ERMA
Daglig lav / høj pris
3,14 / 3,2
SEK
Markedsværdi
23,28 mio. SEK
Aktieomsætning
5,3 t SEK
Volumen
1,7 t
Finanskalender
Generalforsamling
30.06.2023
Delårsrapport
23.08.2023
Delårsrapport
22.11.2023
Årsrapport
21.02.2024